Komori
Precision System Science (7707) · RiskWorsened

Worsening business conditions due to soaring supplies and labor costs

First written in FY2024-Q1. 3 of 6 entries say "Worsened", first in FY2024-Q3. Latest entry: FY2026.

6entries
4years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2024-Q1WorsenedFY2024-Q3 – FY2024RestatedFY2025 – 2026-09-032023: 120232024: 220242025: 120252026: 22026
Same theme, other companies
Profit pressure from higher material, packing and freight, and labor costsA theme 144 companies write about · 147 as a headwind · 0 as a tailwind

Precision System Science moved to the "Worse" side of this theme in 2026, 5 years after the typical company in this theme (2021).

The whole theme swung hardest in 2022: 64 of 104 companies on the "Worse" side.

46 other companies' latest entry also says "Worsened".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 144 companies compared. The sentences above are computed from all 144.
Full recordFilings, disclosures and news, newest first
  1. FY2026WorsenedAnnual report

    「Raw material prices remain high, as do logistics costs and upward pressure on labor costs, while the company also faced difficulty securing stable supplies of semiconductors, other electronic components and raw materials for metals.」

    In addition to previously cited increases in material, labor and transportation costs, difficulty securing stable supplies of semiconductors, electronic components and metals was explicitly stated, broadening the risks on both the cost and supply sides.
  2. 2026-09-03RestatedGeneral Meetings of Shareholders

    「Raw material prices remain high, as do logistics costs and upward pressure on labor costs, while the company also faced difficulty securing stable supplies of semiconductors, other electronic components and raw materials for metals.」

    原材料・物流・人件費の上昇圧力に加え、半導体等の安定調達困難が引き続き記載された。
  3. FY2025RestatedAnnual report

    「Upward pressure on raw material, logistics and labor costs remains, and the challenging cost environment continues.」

    Upward pressure on raw material, logistics and labor costs and the challenging cost environment continue.
  4. FY2024WorsenedAnnual report

    「The bio-testing equipment industry was also affected, with the operating environment becoming increasingly challenging due to higher per-unit material costs, labor costs and transportation costs.」

    In addition to the previously cited increases in material and labor costs, higher transportation costs were explicitly stated, broadening the range of cost-increase factors.
  5. FY2024-Q3WorsenedAnnual report

    「The bio-testing equipment industry was no exception, with the operating environment becoming increasingly challenging due to a significant decline in sales volumes and higher per-unit material costs.」

    The decline in sales volumes was described as a “significant decline,” while higher per-unit material costs also contributed to a more challenging operating environment.
  6. FY2024-Q1First statedAnnual report

    「In the bio-testing equipment industry, the operating environment is becoming increasingly challenging due to sluggish sales volumes as well as higher material and labor costs.」

    In addition to sluggish sales volumes in the bio-testing equipment industry, higher material and labor costs were independently cited for the first time as factors making the operating environment more challenging.
Moved together

"Establishing a Profitable Structure for the Fiscal Year Ending June 2024" moved the same way as this thread, in the same document, in 2 of its 6 moves.

222222★123456
  1. ★This thread
  2. 1Establishing a Profitable Structure for the Fiscal Year Ending June 20242×
  3. 2Performance Targets for the Fiscal Year Ending June 20192×
  4. 3Dependence of sales on the automated DNA extraction system2×
  5. 4Dependence on Sales to Roche Group and QIAGEN Group2×
  6. 5Recurring Losses, Negative Operating Cash Flow and an Early Return to Profitability2×
  7. 6Declining Utilization and Impairment Risk at the Odate Reagent Center2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Precision System Science yet. It last moved in the General Meetings of Shareholders of 2026-09-03: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.